Dr. Jude Fitzgibbon, Barts Cancer Institute - Part 1: Epigenomic Changes in Follicular Lymphoma
 28 May 2013

In this video Dr. Jude Fitzgibbon, Barts Cancer Institute, Queen Mary University of London, discusses his work on the molecular pathogenesis of hematological malignancies. Jude tells SelectScience how his laboratory has developed one of the largest series of sequential tumor tissue worldwide and this enables him to trace the genetic changes in these tumors over time. Jude explains how he has identified several epigenetic changes that are responsible for the onset and potential severity of Follicular Lymphoma, an incurable B cell malignancy.

1 of 82 Page 1 2 3  ... Next 

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!